RT Journal Article
SR Electronic
T1 Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis.
JF Journal of Pharmacology and Experimental Therapeutics
JO J Pharmacol Exp Ther
FD American Society for Pharmacology and Experimental Therapeutics
SP 299
OP 308
VO 219
IS 2
A1 Aiken, J W
A1 Shebuski, R J
A1 Miller, O V
A1 Gorman, R R
YR 1981
UL http://jpet.aspetjournals.org/content/219/2/299.abstract
AB